Utility of apolipoprotein ratio in predicting metabolic risk and microvascular complications in Indian children and young adults with type 1 diabetes mellitus

J Pediatr Endocrinol Metab. 2023 May 5;36(6):547-554. doi: 10.1515/jpem-2022-0403. Print 2023 Jun 27.

Abstract

Objectives: To assess the relationship of apolipoproteins with glycemic control and insulin resistance (IR) in Indian children and youth with type-1 diabetes (T1D) and to assess its utility in predicting metabolic risk (MR) and microvascular complications in these subjects.

Methods: This cross-sectional study included 152 participants aged 6-23 years with T1D. Demographic, anthropometric, clinical, biochemical and body composition data were obtained using standard protocols. IR was calculated using estimated glucose disposal rate (eGDR) and metabolic syndrome (MS) was diagnosed using the international diabetes federation consensus definition 2017.

Results: Apolipoprotein ratio in subjects with T1D had negative and positive correlation with eGDR and HbA1c respectively. Positive correlation of Apolipoproten B and apolipoprotein ratio with urinary albumin creatinine ratio is noted. The ratio had area under curve of 0.766 and 0.737 to predict MR and microvascular complications respectively. The ratio cut-off of 0.536 yielded 77.1 % sensitivity and 61 % specificity to predict MR. On adding the apolipoprotein ratio as a predictor to the regression model developed to predict MR, the R2 and accuracy improved.

Conclusions: The apolipoprotein ratio had significant correlation with IR, microalbuminuria and glycaemic control. The ratio also predicts risk of development of microvascular complications and maybe used to predict MR in subjects with T1D.

Keywords: apolipoprotein ratio; insulin resistance; metabolic syndrome; microvascular complications; type-1 diabetes.

MeSH terms

  • Adolescent
  • Apolipoproteins
  • Blood Glucose / metabolism
  • Child
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 1* / complications
  • Diabetes Mellitus, Type 1* / metabolism
  • Glucose / metabolism
  • Humans
  • Insulin Resistance*
  • Metabolic Syndrome* / complications
  • Metabolic Syndrome* / etiology
  • Young Adult

Substances

  • Glucose
  • Apolipoproteins
  • Blood Glucose